Literature DB >> 26410416

The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Consuelo M López de Padilla1, Timothy B Niewold2.   

Abstract

There is increasing scientific and clinical interest in elucidating the biology of type I Interferons, which began approximately 60 years ago with the concept of "viral interference", a property that reduces the ability of a virus to infect cells. Although our understanding of the multiple cellular and molecular functions of interferons has advanced significantly, much remains to be learned and type I Interferons remain an active and fascinating area of inquiry. In this review, we cover some general aspects of type I interferon genes, with emphasis on interferon-alpha, and various aspects of molecular mechanisms triggered by type I interferons and toll-like receptor signaling by the Janus activated kinase/signal transducer activation of transcription (JAK-STAT) pathway and interferon regulatory factor pathway. We will also describe the role of type I interferons in autoimmune and inflammatory diseases, and its potential use as therapeutic agent.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Idiopathic inflammatory myopathies; Interferon alpha; Interferon beta; Interferon signature; Multiple sclerosis; Rheumatoid arthritis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 26410416      PMCID: PMC4666791          DOI: 10.1016/j.gene.2015.09.058

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  126 in total

1.  Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.

Authors:  Y Yanai; O Sanou; T Kayano; H Ariyasu; K Yamamoto; H Yamauchi; H Ikegami; M Kurimoto
Journal:  J Interferon Cytokine Res       Date:  2001-10       Impact factor: 2.607

2.  Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.

Authors:  Clio P Mavragani; Timothy B Niewold; Niki M Moutsopoulos; Stanley R Pillemer; Sharon M Wahl; Mary K Crow
Journal:  Arthritis Rheum       Date:  2007-12

Review 3.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Authors:  Robert R Graham; Sergey V Kozyrev; Emily C Baechler; M V Prasad Linga Reddy; Robert M Plenge; Jason W Bauer; Ward A Ortmann; Thearith Koeuth; Ma Francisca González Escribano; Bernardo Pons-Estel; Michelle Petri; Mark Daly; Peter K Gregersen; Javier Martín; David Altshuler; Timothy W Behrens; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2006-04-16       Impact factor: 38.330

5.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

6.  Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines.

Authors:  A Tournadre; V Lenief; P Miossec
Journal:  Arthritis Rheum       Date:  2010-07

7.  Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.

Authors:  Maurizio Vitadello; Andrea Doria; Elena Tarricone; Anna Ghirardello; Luisa Gorza
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

Review 8.  Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases.

Authors:  Rafael Denadai; Fábio Vieira Teixeira; Flavio Steinwurz; Ricardo Romiti; Rogério Saad-Hossne
Journal:  J Crohns Colitis       Date:  2012-09-07       Impact factor: 9.071

9.  Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.

Authors:  Silvia N Kariuki; Kyriakos A Kirou; Emma J MacDermott; Lilliana Barillas-Arias; Mary K Crow; Timothy B Niewold
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  Ligand-induced association of the type I interferon receptor components.

Authors:  B Cohen; D Novick; S Barak; M Rubinstein
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

View more
  38 in total

Review 1.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

2.  Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Authors:  Juan M Mejia-Vilet; Samir V Parikh; Huijuan Song; Paolo Fadda; John P Shapiro; Isabelle Ayoub; Lianbo Yu; Jianying Zhang; Norma Uribe-Uribe; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

3.  Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype.

Authors:  Aryn A Price; Dana Tedesco; Mona R Prasad; Kimberly A Workowski; Christopher M Walker; Mehul S Suthar; Jonathan R Honegger; Arash Grakoui
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.

Authors:  Lin Gao; Anna K Bird; Nida Meednu; Kristin Dauenhauer; Jane Liesveld; Jennifer Anolik; R John Looney
Journal:  Arthritis Rheumatol       Date:  2017-07-11       Impact factor: 10.995

Review 5.  Genetics of human lupus nephritis.

Authors:  Taro Iwamoto; Timothy B Niewold
Journal:  Clin Immunol       Date:  2016-09-28       Impact factor: 3.969

6.  ARID3a gene profiles are strongly associated with human interferon alpha production.

Authors:  Michelle L Ratliff; Joshua Garton; Lori Garman; M David Barron; Constantin Georgescu; Kathryn A White; Eliza Chakravarty; Jonathan D Wren; Courtney G Montgomery; Judith A James; Carol F Webb
Journal:  J Autoimmun       Date:  2018-10-05       Impact factor: 7.094

Review 7.  STING-Mediated Lung Inflammation and Beyond.

Authors:  Marie-Louise Frémond; Yanick J Crow
Journal:  J Clin Immunol       Date:  2021-02-02       Impact factor: 8.317

Review 8.  Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.

Authors:  Ashley A Stegelmeier; Maedeh Darzianiazizi; Kiersten Hanada; Shayan Sharif; Sarah K Wootton; Byram W Bridle; Khalil Karimi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 9.  Type I interferon antagonists in clinical development for lupus.

Authors:  Jacqueline L Paredes; Timothy B Niewold
Journal:  Expert Opin Investig Drugs       Date:  2020-09-01       Impact factor: 6.206

10.  Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-alpha production.

Authors:  Ya-Chiao Hu; I-Jung Tsai; Hui-Yao Hsu; Bor-Luen Chiang; Yao-Hsu Yang
Journal:  Arthritis Res Ther       Date:  2021-06-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.